packageCytarabine

cytarabine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cytarabine is an antineoplastic antimetabolite used to treat blood cancers such as acute myeloid leukemia, other leukemias, and several lymphomas, as well as myelodysplastic syndrome and meningeal tumors. It is an approved medicine, appears on the WHO essential medicines list, and is widely used in cancer care, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q180983 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:cytarabine
ATC codes:L01BC01
DrugBank:DB00987
PubChem CID:6253
ChEBI:28680
Wikidata:Q180983
formula:C9H13N3O5
molar mass:243.219 g/mol (PubChem CID 6253)
logP:-2.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown